Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights

Novartis’ decision to spin out Sandoz, its generics and biosimilars business, into a separate, stand-alone company is the latest move in the highly cost-competitive generics market. What was behind Novartis’ decision, and how does it fit with other recent deals?

DCAT Insights Value Chain Publication - IGM Creative Group

How is the US Bio/Pharma Market Performing? - DCAT Value Chain Insights

Retail & CPG Global Business Services Moving Up The Value Chain

Kwon Kim on LinkedIn: Pharma Industry Outlook: Where is the Growth? - DCAT Value Chain Insights

State of the Market - Q1 2023

Global API Market: Crunching the Numbers - DCAT Value Chain Insights

Car Carrier Market Share, Size, Share

Week in Review: Adapting to Tomorrow—Bridging Pharma Gaps, Changing Consumer Habits & Reinforcing Food Logistics

DCAT Week Preview 2023 Edition by DCAT - Drug, Chemical and Associated Technologies Association - Issuu

The 7 Data Habits of World-Class Product Companies